The San Diego Entrepreneurs Exchange has organized a meeting to discuss how local entrepreneurs have obtained federal funding, especially Small Business Innovative Research (SBIR) grants. John Finn, the chief scientific officer at Trius Therapeutics, will make a presentation, which will be followed by a roundtable discussion with the CEO of Orphagen Pharmaceuticals, the founding CEO of Mandala Biosciences, and Scott Struthers, CSO and funder of Crinetics Pharmaceuticals. Networking and registration begin at 5 p.m., or register online here.